by Caden Pearson The U.S. Food and Drug Administration’s (FDA) initial response to complaints about Abbott’s infant formula plant was “too slow” and some decisions could have been “more…
March 2, 2026
by Caden Pearson The U.S. Food and Drug Administration’s (FDA) initial response to complaints about Abbott’s infant formula plant was “too slow” and some decisions could have been “more…